IVD_Contract_Manufacturing_Market.JPG

IVD Contract Manufacturing Market Size, Share & Trends Analysis Report By Type of Nanoparticle Formulated (Organic, Inorganic, and Carbon-based Nanoparticles), By Organic Nanoparticle Formulated, By Inorganic Nanoparticle Formulated, By Scale of Operation, Region, And Segment Forecasts, 2025-2034

Report Id: 1882 Pages: 180 Published: 11 June 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

IVD Contract Manufacturing Market Size is valued at 15.88 billion in 2024 and is predicted to reach 50.50 billion by the year 2034 at a 12.4% CAGR during the forecast period for 2025-2034.

IVD Contract Manufacturing Market INFO

Key Industry Insights & Findings from the Report:

  • The growing occurence of infectious diseases and the need for early diagnosis drive the demand for IVD devices, which in turn drives the growth of the IVD contract manufacturing market.
  • Increasing regulatory complexities are driving IVD companies to outsource manufacturing to contract manufacturers, driving growth in the IVD Contract Manufacturing Market.
  • Asia Pacific region dominated the 2023 market and accounted for a global revenue share.
  • The certifications and appprovals are one of the key challenges hindering the growth of the IVD contract manufacturing market.

In vitro diagnostics (IVDs) are medical instruments/devices that use biological samples, such as blood or tissue, to diagnose various diseases and infections. IVD tests and assays range from simple tests like SARS-CoV-2 tests to complex laboratory IVD tools.

The global IVD market is the largest segment of the medical technology industry and is expanding with healthcare investments and an increasing focus on early detection and preventive care. The IVD industry is constantly evolving to meet the needs of clinical demands and personalized treatments.

The main reasons for the growth of this market are increasing demand for cheaper and better products, IVD OEMs gaining a foothold in the capital market, and the reduced risk of development failure. Additionally, the emergence of CMO facilities in various countries will likely boost the IVD contract manufacturing market in the next few years. However, growing shortages of skilled workers, the risk of patent infringement and other concerns about intellectual property security are holding back business growth. 

Competitive Landscape:

Some of the Key Players in the IVD Contract Manufacturing Market :

  • Avioq Inc.
  • Biokit
  • Celestica Inc.
  • Cenogenics Corporation
  • Cone Bioproducts
  • Fujirebio
  • Invetech
  • Jabil Inc.
  • Kimball Electronics, Inc.
  • Kmc Systems
  • Meridian Biosciences
  • Nemera
  • Nolato Gw, Inc.
  • Nova Biomedical
  • Phillips Medsize Corporation
  • Sanmina Corporation
  • Savyon Diagnosticss
  • Stratec
  • Te Connectivity Ltd.
  • Thermofisher
  • Viant Medical Holdings Inc.
  • West Pharmaceutical Services
  • Other Prominent Players

Market Segmentation:

The IVD contract manufacturing market is segmented based on device type, technology, and services. The device type segment comprises IVD Equipment and IVD Consumables. By technology, the market is bifurcated into immunoassay, clinical chemistry, molecular diagnostics, microbiology, hematology, coagulation & hemostasis, and others. By services, the market is categorized into manufacturing services, assay development services, and other services.

The IVD Equipment is expected to drive the IVD contract manufacturing market in the upcoming years

IVD contract manufacturing is surging rapidly. There are many reasons why businesses choose to outsource their IVD production. Maybe they have insufficient facilities for manufacturing large quantities in-house, or they don't have the necessary skills. Here, contractor manufacturers play an essential role in providing high-quality, low-cost, and efficient products as compared to what businesses can achieve on their own. Moreover, contracting companies can often provide more services than the business itself can provide.

This contracting facility is also beneficial for startups and small-scale companies to design, produce and sell their equipment. For instance, in November 2022, Jabil Inc. expanded its developmental capabilities by opening a design center in Wrolaw, Poland. This would allow the company to develop leading-edge technologies for multiple industries, including the automotive and healthcare sectors.

The Assay Development segment is growing at the highest rate in the IVD contract manufacturing market

Many outsourced companies in the IVD field choose to offer assay development services as they have limited financial capacity. Factors such as resource availability, growth and efficiency of R&D, reduced development time, lower cost, high efficiency, and expertise in assay development are considered to be the driving factors for the IVD contract manufacturing market.

Regionally, Asia Pacific led the IVD contract manufacturing market in 2022

Asia Pacific IVD contract manufacturing market dominated in 2022 and is expected to continue the same over the forecast period 2023-2031. The growth of this market can be attributed to rising demand for in vitro diagnostic tests, increased prevalence of diseases & infections, and growing mergers and acquisitions in the IVD sector.

Recent Developments:

  • In March 2024, Fujirebio and Beckman Coulter Extended Their Collaboration to Develop Blood-Based Neurodegenerative Disease Diagnostics That Are Patient-Friendly. Fujirebio and Beckman Coulter worked together to develop novel biomarkers that corresponded with monoclonal antibody-based Alzheimer's disease therapeutics that were recently approved.

IVD Contract Manufacturing Market Report Scope:

Report Attribute

Specifications

Market Size Value In 2024

USD 15.88 Bn

Revenue Forecast In 2034

USD 50.50 Bn

Growth Rate CAGR

CAGR of 12.4% from 2025 to 2034

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2025 to 2034

Historic Year

2021 to 2024

Forecast Year

2025-2034

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Device Type, By Technology, By Services

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia

Competitive Landscape

Avioq Inc., Biokit, Celestica Inc., Cenogenics Corporation, Cone Bioproducts, Fujirebio, Invetech, Jabil Inc., Kimball Electronics, Inc., Kmc Systems, Meridian Biosciences, Nemera, Nolato Gw, Inc., Nova Biomedical, Phillips Medsize Corporation, Sanmina Corporation, Savyon Diagnosticss, Stratec, Te Connectivity Ltd., Thermofisher, Viant Medical Holdings Inc., West Pharmaceutical Services, And Others.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Deprecated: stripslashes(): Passing null to parameter #1 ($string) of type string is deprecated in /home/z8nbkwptb7pj/public_html/report-details.php on line 233

Segmentation of IVD Contract Manufacturing Market -

IVD Contract Manufacturing Market By Device Type-

  • IVD Equipment
  • IVD Consumables

IVD Contract Manufacturing Market

IVD Contract Manufacturing Market By Technology-

  • Immunoassay
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Hematology
  • Coagulation and Hemostasis
  • Others

IVD Contract Manufacturing Market By Services-

  • Manufacturing Services
  • Assay Development Services
  • Other Services

IVD Contract Manufacturing Market By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Email field cannot be blank!(Use email format)
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
3260
Security Code field cannot be blank!
Frequently Asked Questions

The RNA Editing Market Size is valued at USD 15.2 billion in 2023 and is predicted to reach USD 23.1 billion by the year 2031

The RNA Editing Market is expected to grow at a 5.60% CAGR during the forecast period for 2024-2031.

ProQR Therapeutics NV, Sirna Therapeutics, Inc., Shape Therapeutics, Inc., Korro Bio, In., Beam Therapeutics, Inc., QIAGEN N.V., UniquQuire NV, LAVA T

Type Of RNA, Application, And Technique are the key segments of the RNA Editing Market.

North American region is leading the RNA Editing Market.